BioSpace News Archive

Drug Development

BioArctic Announces Start of Phase 1 Study of ABBV-0805 for Parkinson’s Disease

BioArctic AB announced that the first clinical study with ABBV-0805 has started in the U.S. AbbVie is responsible for the clinical development of ABBV-0805.

March 13, 2019
·
3 min read
Business

Innovent Announces 2018 Annual Results

Delivering Significant Progress with Drug Pipeline Development, Commercialization Readiness and Operation Excellence

March 13, 2019
·
10 min read
Business

Kemin Industries Discusses New Insights Related to Efficient Nutrient Absorption

Global ingredient manufacturer hosts conference with industry experts to discuss new insights on nutrient variability and the link between nutrition and animal health

March 13, 2019
·
7 min read
Policy

Media Advisory - The Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, announces Canada’s response to the threat of African swine fever

The Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, will announce measures taken by the Government of Canada to help prevent the introduction of African swine fever into Canada.

March 13, 2019
·
1 min read
Business

Contextual Genomics Names Michael Ball as Chief Executive Officer

Contextual Genomics, a leading Canadian cancer genomics company, announced that its Board of Directors has named Michael Ball as Chief Executive Officer.

March 13, 2019
·
4 min read
Business

World Happiness Summit® Opens Third Edition Friday In Miami

WOHASU® LLC announced that the third annual World Happiness Summit® starts Friday March 15, 2019, at the University of Miami, the official host of the Summit.

March 13, 2019
·
2 min read
FDA

Aerie Pharma’s 2nd Glaucoma Drug Gets FDA Approval

The U.S. Food and Drug Administration (FDA) approved Aerie Pharmaceuticals Rocklatan (netarsudil and latanoprost ophthalmic solution) to decrease elevated intraocular pressure (IOP) in open-angle glaucoma or ocular hypertension.

March 13, 2019
·
2 min read
·
Mark Terry
Deals

Germany’s BioNTech Taps Banks to Prepare for $800 Million IPO

For BioNTech, the IPO will follow a funding round that brought about $270 million into the coffers of the privately-held company.

March 13, 2019
·
2 min read
·
Alex Keown
Business

Oxford Biomedica Teams With Microsoft to Use AI to Improve Gene Therapies

The goal is to improve the yield and quality of next-generation gene therapy vectors—typically viruses—using artificial intelligence (AI) and machine learning.

March 13, 2019
·
3 min read
·
Mark Terry
Drug Development

Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study

While the primary endpoint of disease-free survival was not met, Celgene said overall survival, which was a secondary endpoint, was improved by the combination treatment.

March 13, 2019
·
2 min read
·
Alex Keown